ArticleCancers2022

The Third Joint Meeting on Lung Cancer of the FHU OncoAge (University Côte d'Azur, Nice, France) and the University of Texas MD Anderson Cancer Center (Houston, TX, USA). Understanding New Therapeutic Options and Promising Predictive Biomarkers for Lung Cancer Patients.

Paul Hofman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.